Literature DB >> 6602378

Clot-selective coronary thrombolysis with tissue-type plasminogen activator.

S R Bergmann, K A Fox, M M Ter-Pogossian, B E Sobel, D Collen.   

Abstract

Coronary thrombolysis, an intervention that can abort the sequelae of acute myocardial infarction, was accomplished within 10 minutes in dogs by intravenous administration of clot-selective, tissue-type plasminogen activator. In addition to inducing clot lysis, this promising fibrinolytic agent restored intermediary metabolism and nutritional myocardial blood flow, detectable noninvasively with positron tomography, without inducing a systemic fibrinolytic state.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6602378     DOI： 10.1126/science.6602378

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  27 in total

Review 1.  Tracer kinetic modeling in nuclear cardiology.

Authors:  T R DeGrado; S R Bergmann; C K Ng; D M Raffel
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

2.  Human tissue-type plasminogen activator gene located near chromosomal breakpoint in myeloproliferative disorder.

Authors:  T L Yang-Feng; G Opdenakker; G Volckaert; U Francke
Journal:  Am J Hum Genet       Date:  1986-07       Impact factor: 11.025

Review 3.  Imaging of myocardial fatty acid metabolism with PET.

Authors:  Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 4.  Professor Keith AA Fox.

Authors:  Keith Aa Fox
Journal:  Eur Cardiol       Date:  2016-08

5.  Tissue-type plasminogen activator. Therapeutic potential in thrombotic disease states.

Authors:  D Collen
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

6.  Superselective Intra-arterial Thrombolysis for Acute Cardioembolic Stroke in a Child with Idiopathic Dilated Cardiomyopathy. A Case Report.

Authors:  E Kitzmüller; A Gruber; M Marx; M Schlemmer; M Wimmer; B Richling
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

7.  Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator.

Authors:  J Owen; K D Friedman; B A Grossman; C Wilkins; A D Berke; E R Powers
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

8.  A faster-acting and more potent form of tissue plasminogen activator.

Authors:  B A Keyt; N F Paoni; C J Refino; L Berleau; H Nguyen; A Chow; J Lai; L Peña; C Pater; J Ogez
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells.

Authors:  R J Kaufman; L C Wasley; A J Spiliotes; S D Gossels; S A Latt; G R Larsen; R M Kay
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

10.  Thrombolytic efficacy of recombinant human microplasmin in a canine model of copper coil-induced coronary artery thrombosis.

Authors:  Christophe Dommke; Oliver Turschner; Jean-Marie Stassen; Frans Van de Werf; H Roger Lijnen; Peter Verhamme
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.